Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference
Event: | 2021 |
Format: | Presentation & Fireside Chat |
Date: | |
Time: |
An audio webcast of the presentation will be available online at the Nuwellis’ investor relations website, https://ir.nuwellis.com. Additionally, a replay will be available for 90 days after the presentation.
About
About the Aquadex SmartFlow System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
CONTACTS
INVESTORS:
Matt.bacso@gilmartinir.com
MEDIA:
Health+Commerce
260-336-6202
jstebing@healthandcommerce.com
Source: Nuwellis, Inc.